Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markku Partinen

Showing results (151-160 of 202) with videos related to

Pageof 21
Sort By:
Plos One|August 17, 2013
No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in FinlandKrister Melén, Markku Partinen, Janne Tynell, et al.
European Journal of Neurology|September 4, 2012
European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research SocietyDiego Garcia-Borreguero, Luigi Ferini-Strambi, Ralf Kohnen, et al.
Autoimmunity|May 22, 2016
Autoantibody targets in vaccine-associated narcolepsyAnna Häggmark-Månberg, Arash Zandian, Björn Forsström, et al.
Journal of Sleep Research|November 18, 2022
The role of sleep and dreams in long-COVIDSerena Scarpelli, Alessandra De Santis, Valentina Alfonsi, et al.
Plos One|April 4, 2012
Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in FinlandMarkku Partinen, Outi Saarenpää-Heikkilä, Ismo Ilveskoski, et al.
Chest|October 30, 2020
Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP: A Randomized TrialJean-Louis Pépin, Ognian Georgiev, Rumen Tiholov, et al.
Sleep Medicine Reviews|April 21, 2020
Diagnosis of central disorders of hypersomnolence: A reappraisal by European expertsGert Jan Lammers, Claudio L A Bassetti, Leja Dolenc-Groselj, et al.
The Lancet. Neurology|June 3, 2008
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trialClaudia Trenkwalder, Heike Benes, Werner Poewe, et al.
Plos One|December 16, 2014
Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy riskOuti Vaarala, Arja Vuorela, Markku Partinen, et al.
Sleep Medicine|September 4, 2010
Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic studyWolfgang H Oertel, Heike Benes, Diego Garcia-Borreguero, et al.
Pageof 21

Showing results (151-160 of 202) with videos related to

Sort By:
Pageof 21
Plos One|August 17, 2013
No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in FinlandKrister Melén, Markku Partinen, Janne Tynell, et al.
European Journal of Neurology|September 4, 2012
European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research SocietyDiego Garcia-Borreguero, Luigi Ferini-Strambi, Ralf Kohnen, et al.
Autoimmunity|May 22, 2016
Autoantibody targets in vaccine-associated narcolepsyAnna Häggmark-Månberg, Arash Zandian, Björn Forsström, et al.
Journal of Sleep Research|November 18, 2022
The role of sleep and dreams in long-COVIDSerena Scarpelli, Alessandra De Santis, Valentina Alfonsi, et al.
Plos One|April 4, 2012
Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in FinlandMarkku Partinen, Outi Saarenpää-Heikkilä, Ismo Ilveskoski, et al.
Chest|October 30, 2020
Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP: A Randomized TrialJean-Louis Pépin, Ognian Georgiev, Rumen Tiholov, et al.
Sleep Medicine Reviews|April 21, 2020
Diagnosis of central disorders of hypersomnolence: A reappraisal by European expertsGert Jan Lammers, Claudio L A Bassetti, Leja Dolenc-Groselj, et al.
The Lancet. Neurology|June 3, 2008
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trialClaudia Trenkwalder, Heike Benes, Werner Poewe, et al.
Plos One|December 16, 2014
Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy riskOuti Vaarala, Arja Vuorela, Markku Partinen, et al.
Sleep Medicine|September 4, 2010
Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic studyWolfgang H Oertel, Heike Benes, Diego Garcia-Borreguero, et al.
Pageof 21